CONTENTS II. Lil. IV. VI. VIL. VIII. IX. l. Early Radiation 2. Control Populations th we we we tw he te ew ee ee ew te ew wt wt eh ht tt te 2. eh 2. 6 1 2 2 ee ee te ww we ee ww 6 2 ee ee . 2. 2. 1. 6 © ee ee 2. Residual Radiation... .. E. Data Evaluation ...... 6 © GENERAL MEDICAL SURVEYS ... . 2. + A. Background . 2. 2 6 6 6 6 8 oe 8h @ Methods . 2. 6 1 2 6 we ew ee B. l. Procedures . 1. 2. 6 © © © © © . 1... we ee th we ww ew we 5.4. e eee se ee we we wae « © © « © © @ eh wo ee te we ee ew we we et we we © © © we et ew ww we te ew 6 6 6 ws es tt 6 ee we te ee we ee Results ... a Cc. HEMATOLOGIC OBSERVATIONS A. Background . . 2. 6 1 0 2 © © et ew we we th we we te B. Methods . . 2. 6 6 «© © © © © © © © © eo ee eh tl Cc. Results and Discussion... 6. 6 2 1 ee ee ew we te we ee we GROWTH AND DEVELOPMENT . . . 6 2 2 es 0 ee ot to ee eh ws Background . 2. 2 6 6 6 2 6 ew 8 ew ew te we te eh A. B. Methods . . 2. 6 6 6 es ee ew ew ee et ee te Cc. Results . 2. 6 6 6 ew ee we ee wt ee ww ee et D. Discussion .. . . ee ww AGING, IMMUNOLOGICAL, CHROMOSOME, "AND " GENETIC “STUDIES | A. Aging Studies .....66 B. Immunological Studies ... a Cc. Chromosome and Genetic Studies a 1. Chromosome Studies ..... . 2. Isoleucine Misincorporation inn Hemoglobin. A of Marshallese 3. Detection of Mutant Proteins . PARASITOLOGIC SURVEYS AND SUPPRESSIVE ANTI- HELMINTH TREATMENT | ON RONGELAP AND UTIRIK, 1977-1979 . 2. 1 6 0 ww eh ew th we ee A. Background . . 2. 1 2 2 © © ee 8 wee we we wwe tw et ee B. Methods ... a Cc. Results and Discussion Pe D. Conclusions . . 2 6 «5 «© © © © © eo ee we we wt we ht DIABETES SURVEY . 2... NEOPLASIA (NON-THYROID) A. Malignancies . . 6. 6 B. Benign Tumors . 2. 6 0. 0 .. 6 1 6 + ee we ee ew th - 2. ee ew ee ee ew eh et we ee 6 ee ee ee ew ew we ee te ee te we te we ew ee ee ee ee C. Pituitary Tumor . . 6... 6 ee 2 ee ee te we THYROID ABNORMALITIES . . 1. 2 2 6 © we ew we ee ee A. Background (Chronology of Developments) - xii - lil h- ee he ww et ee ee ew tw oe et ew ee ee © 6 to oe we ee ee ee we ee ew ee ee we we COIN NW WHR eK DEDICATION ~. 2 6 6 ew 6 ee ee PREFACE «6 6 ee ee ee ee ACKNOWLEDGMENTS . 2. 6 6 ee © INTRODUCTION . . «2 2 © 2 6 © A. Background . . 2. 6 6 2 6 © B. The Accident . . 1. 2 6 ee Cc. Early Clinical Effects . 1. D. Dosimetric Evaluation . 2. we 36 36 36 38 41 43 47 47 48 49 53 53